HappeningToo topic
Abaloparatide reports
Browse community reports connected to Abaloparatide. These reports can show that other people are describing similar experiences, but they do not prove that Abaloparatide caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
48 problems
Abdominal Discomfort while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and abdominal discomfort appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Distension while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and abdominal distension appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and abdominal pain upper appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and abdominal pain appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and alopecia appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and anxiety appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and back pain appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chest Discomfort while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and chest discomfort appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and chills appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and constipation appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and decreased appetite appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and diarrhea appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and dizziness appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Mouth while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and dry mouth appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and dyspepsia appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and fatigue appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and feeling abnormal appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flushing while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and flushing appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Head Discomfort while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and head discomfort appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and headache appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Heart Rate Increased while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and heart rate increased appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and hives appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hot Flush while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and hot flush appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and hypotension appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and insomnia appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and itching appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and malaise appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Migraine while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and migraine appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and muscle spasms appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and muscular weakness appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and myalgia appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and nausea appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Neck Pain while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and neck pain appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and pain appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Palpitations while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and palpitations appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and rash appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and shortness of breath appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and skin redness appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleep Disorder while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and sleep disorder appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and sleepiness appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tachycardia while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and tachycardia appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and tingling or pins and needles appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and tremor appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vertigo while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and vertigo appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and vomiting appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and weakness appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and weight decreased appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Abaloparatide
FDA FAERS contains adverse-event reports in which Abaloparatide and weight increased appear together. This does not establish that Abaloparatide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →